GATA6 has been shown to be misexpressed in CRC cells from the earliest stages of dysplasia continuing to late metastatic lesions, pointing to a crucial role in the pathogenesis and progression of colon cancer [25, 26]. Here, GATA6 is linked to colorectal carcinoma.